Dermatological Manifestations in
Chronic Kidney Disease Patients on Hemodialysis
Dorchhom K1, Kumar A2,
Bansal N3, Pandey AN4, Mehta A5, Bisth JS6, Varma A7
1Dr Dorchhom Khrime, Associate Professor, Department of Medicine, 2Dr
Alok Kumar, Incharge Nephrology Unit, Associate Professor, Department
of Medicine, 3Dr Nitin Bansal, Associate Professor, Department of
Medicine, 4Dr Amar Nath Pandey, Associate Professor, Department of
Medicine, 5Dr Anil Mehta, Professor and Head, Department of
Dermatology, 6Dr Jitendra Singh Bisth, Associate Professor Department
of Dermatology, 7Dr Amit Verma, Professor and Head, Department of
Medicine. All are affiliated with Shri Guru Ram Rai Institute of
Medical and Health Sciences Patel Nagar, Dehradun, Uttarakhand, India
Address for
correspondence: Dr Alok Kumar, Email:
alokkraj@rediffmail.com
Abstract
Background and Objective:
Chronic kidney disease patients on dialysis face various cutaneous
problems. Common problems are xerosis, pruritus, pallor, pigmentation
changes, hair changes and nail changes. We planned to look for
cutaneous alterations in our patients on maintenance dialysis. Material and Methods:
We included all patients on maintenance hemodialysis. We recorded their
demographic profile and relevant investigations. All patients were
examined by department of medicine and findings were confirmed by
dermatologist. Specific investigations like skin biopsy, culture and
sensitivity for bacterial infections, Gram's stain, potassium hydroxide
mount and fungal culture were done where indicated. Results: There was
one hundred forty patients. Mean age of patients was
38.7±7.4 years. Gender ratio was 1.32:1 (male: female). Mean
duration of dialysis was 11.7±5.6 months. All patients had
at least one cutaneous manifestation. Thirty four (24.28%) patients had
two cutaneous manifestations. Twenty one (17.85%) patients had three or
more cutaneous manifestations. Xerosis was seen in 74.8% patients.
Pigmentary changes were seen in 43.57% patients. Nail changes were seen
in fifty seven patients. Half and half nail was seen in twenty six
(18.57%) patients. Hair changes were seen in forty nine (35%)
patients. Cutaneous infections were seen in forty six patients. Most
common infection was dermatophytosis in twenty eight patients (20%). Conclusion: CKD
patients on dialysis suffer with multiple skin problems. Early
detection of these problems like xerosis, cutaneous infection, and
pruritus might result in improvement in quality of life.
Key words:
Chronic Kidney Disease, Cutaneous Manifestations, Xerosis, Pruritus,
Half and Half nail
Manuscript received:
10st Sep 2014, Reviewed:
20th Sep 2014
Author Corrected:
16th Oct 2014, Accepted
for Publication: 30th Oct 2014
Introduction
Chronic kidney disease (CKD) is associated with various dermatological
manifestations. These could be due to renal insufficiency or due to
disease causing chronic kidney disease. Systemic lupus erythematosus or
Vasulitis had been described with typical skin rashes. On other hand
chronic renal insufficiency can also cause lot of skin manifestations.
These have been described in various studies in almost all patients on
maintenance hemodialysis. [1].There are different kinds of cutaneous
alterations described in CKD like Xerosis, pruritus, pallor,
hyperpigmentation, half and half nail, and brittle hair [2]. In this
background we took this study to look for cutaneous alterations in
patients of CKD on maintenance hemodialysis at our institute.
Material
and Methods
One hundred forty patients of CKD on maintenance haemodialysis from May
2008 to May 2013 at our institute were included. All patients underwent
detailed dermatological examination by internist and later confirmed by
dermatologist. Their basic demographic profile was noted. We collected
data for cause of kidney disease, duration of renal disease, duration
of dialysis. Their haemoglobin, serum urea, serum creatinine, serum
calcium, serum phosphorus were also recorded. Adequacy of dialysis was
calculated by kt/v using Daugirdas formula. Patients on peritoneal
dialysis were excluded. Patients of acute renal injury were also
excluded. Specific investigations like skin biopsy, culture and
sensitivity for bacterial infections, Gram's stain, potassium hydroxide
mount and fungal culture were done where indicated, after informed
consent. Routine investigations for monitoring renal functions were
recorded. The severity of xerosis was assessed by a modified version of
the grading by Morton [3]: grade 0 (smooth skin), grade 1 (rough skin)
and grade 2 (rough skin with scaling). Continuous variables were
recorded as mean with standard deviation. Chi square test and Z test
were used to compare data. P value of <.05 was considered
significant
Results
There were one hundred forty patients. Mean age of patients was
38.7±7.4 years (19 to 73 years).There were eighty seven
males and fifty three females. Gender ratio was 1.32:1 ( male: female).
Mean duration of dialysis was 11.7±5.6 months. Range for
duration of hemodialysis was 2 months to 5 years. Mean Haemoglobin was
9.4±1.5 gm %. Mean blood urea and serum creatinine level
were 188±27.3 mg% and 8.7±1.9 mg%. Mean serum
calcium and phosphorus level were 8.9±1.1mg% and
6.8±2.3mg%. Mean serum albumin level were
3.2±.3mg%. Causes of chronic kidney disease have been shown
in figure 1. Mean kt/v was 1.16±.03.
Table 1: showing
prevalence of various dermatological conditions
S.
No.
|
Skin
Condition
|
No.
of patients
|
Percentage
|
1
|
Xerosis
|
104
|
74.8
|
2
|
Pallor
|
93
|
66.4
|
3
|
Pruritus
|
69
|
49.28
|
4
|
Pigmentary
changes
|
61
|
43.57
|
5
|
Nail
changes
|
57
|
40.71
|
6
|
Hair
changes
|
49
|
35
|
7
|
Cutaneous
infection
|
46
|
32.8
|
8
|
Oral
mucosa changes
|
44
|
29.28
|
9
|
Purpura
|
14
|
10
|
10
|
Kyrle
Disease
|
4
|
2.85
|
Table 2: Severity of
Xerosis
Grade
|
No.
Of Patients
|
Percentage
|
0
|
36
|
25.71
|
1
|
61
|
43.57
|
2
|
43
|
30.72
|
All patients had at least one cutaneous manifestation. Thirty four
(24.28%) patients had two cutaneous manifestations. Twenty one (17.85%)
patients had three or more cutaneous manifestations. Xerosis was seen
in 74.8% patients. Majority had grade 1 xerosis (table 2). Pallor was
observed in 93 patients. Pruritus was seen in sixty nine patients. It
was refractory in 28(20%) patients. Pigmentary changes were common and
seen in 43.57% patients. Diffuse brown pigmentation was observed in
forty two patients and yellow pigmentation was seen in nineteen
patients. Nail changes were seen in fifty seven patients. Half and half
nail was seen in twenty six (18.57%) patients. Half and Half nail was
seen in 16 diabetic patients (16 of 58) and 10 (10 of 82) non diabetic
patients. Z score was 2.30 which is significant at p<.05.
Beau’s line was seen in twelve (8.57%) patients. Platynychia
was seen in ten (7.14%) patients. Absence of lunula was seen in nine
(6.42%) patients. Onychomycosis was seen in twenty nine patients. 21
patients were diabetic and remaining were non diabetic. Z test showed
score of 4.013 (p<.01).
Hair changes were seen in forty nine (35%) patients. Thirty three
patients had sparse hair on scalp. Sixteen patients had lustreless
hair. Cutaneous infections were seen in forty six patients. Most common
infection was dermatophytosis in twenty eight patients (20%) Pyoderma
was seen in ten patients (7.14%). Scabies was seen in six (4.28%)
patients. Five patients (3.57%) had Herpes zoster. Oral mucosa changes
were seen in forty six patients. Macroglossia was found in twenty three
(16.42%) patients Xerostomia was seen in fourteen (10%) patients.
Ulcerative stomatitis was observed in nine (7.2%) patients. Purpura was
observed in 10 % patients. Kyrle disease or acquired perforating
dermatitis was seen in four patients and all had diabetic nephropathy.
Two patients showed evidence of metastatic calcification of skin
Discussion
We observed some kind of renal involvement in all patients [4]. It has
been observed by many authors. Xerosis was the most common
dermatological manifestation seen in 74.8% patients. Uday kumar et al
and other authors also found similar results [2,3,5,6]. We
observed 43.57% patients with grade 1 and 30.71% with grade 2
but Uday kumar et al had 71 % with grade 1. It may be due to
more number of diabetic patients in our study. We had 58% diabetic
patients while Uday Kumar et al had 38%. Diabetic patients have severe
xerosis [2]. It may be due to reduction of size of ecrine sweat glands
[7]. Pallor was next common manifestation seen in 66.4% patients. It is
due to anaemia seen in majority of patients in CKD. Its incidence is in
same range in experience of other study [2]. Deficient erythropoietin
production by the failing kidneys and dietary deficiencies of iron,
folic acid, and vitamin B12 contribute to anemia [8]. Uremic pruritus
is one of the most troublesome symptom in patients with chronic renal
failure. It was seen in 49% patients in our study. Prevalence of
pruritus has been described 19 to 90% by different authors. [2,9,10].
The etiology of pruritus in CRF is not clear however, it has been
associated with advance uremia [11]. Retention of middle molecules such
as beta-2 microglobulin, advanced glycosylation end products, and
parathyroid hormone also has been implicated in pathogenesis of uremic
pruritus [9]. Neuuronal theory is also considered a probable cause for
CRF pruritus [12].
Pigmentary changes were seen in 43% patients in our study. Other
authors reported these changes 31-43% [2,10]. Diffuse brown
hyperpigmentation is caused by increased levels of
β-melanocyte stimulating hormone due to inadequate excretion
through kidney and dialysis [13]. Yellowish tinge is due to excess
deposition of two major pigments namely carotenoids and lipochromes in
the epidermis and subcutaneous tissue [14]. Nail changes were found in
40.71% patients in our study. Other authors found these abnormalities
in 22 to 60% [10,12,15]. Most common abnormality was half and half nail
in 18.57% patients. It has also been described most common nail change
in uremia by others ranges from 16 to 50% [5,16,17] in comparison to
1.4% in general population [16]. Half and half nail was more common
with diabetic patients. Uday Kumar et al [2] also found same
association. Other nail changes were platynychia, Beau’s
lines and absence of lunula. Similar changes had been described in
other studies [16,17]. Onychomycosis was seen in 20.71% patients. Uday
Kumar et al [2] found incidence of onychomycosis 19%. We found
increased incidence of onychomycosis in diabetic patients.
Hair changes were seen in 35% patients in present study. Sparse hair
were found in 23% patients. It was the commonest hair change. Diffuse
hair loss had been described as most common hair change by others
[2,4]. Dry lustreless hair were found in12%. Lustreless hair is due to
decresed sebum secretion [18]. Cutaneous infections were found in 32.8%
patients. Deshmukh et al also found prevalence of cutaneous infections
34% [10] while Sultan et al reported cutaneous infection in 40%
patients [16]. Dermatophytosis were the commonest infection in 20%
patients, which is also found in other study [10]. Pyoderma, scabies
and Herpes zoster were other cutaneous infections. Similar pattern was
found in study by Deshmukh et al [10]. Increased susceptibility to
infection in renal failure is due to diminished T and B lymphocyte
function and count, and reduced natural killer cell activity [19].
Oral mucosal changes were seen in 29% patients. There are reports of
oral mucosal changes from no significant changes [15] to involvement in
90% patients [20]. Macroglossia (tongue sign of uremia was seen in
14.4% cases. Xerostomia and ulcerative stomatitis was seen in 10% and
7% patients. We observed lesser oral mucosal changes than other Indian
study [2]. It may be due to geographical variation. Purpura was seen
in10% cases. Uday Kumar et al also found purpura in 9% cases [2].
Increased vascular fragility, abnormal platelet function and the use of
heparin during dialysis are the main causes of abnormal bleeding in the
dialysis patients [21]. Kyrle disease was found in 2.85% patients. Its
prevalence had been described 3% by Khanna et al [22] and 17 % by
Deshmukh et al [10]. Gynecomastia was also seen in 2.85% cases. Udai
Kumar [2] found gynecomastia in 1% and other study found in 40% cases
[23]. Metastatic calcification was also seen in two patients. It was
also seen in 2% cases in study by Sultan et al [16]. Nephrogenic
fibrosing dermopathy (NFD), a recently described disorder of unknown
etiology, resembles scleromyxedema in some aspects. We did not see case
of NFD in our patients. Other Indian studies also did not find NFD in
their patients [2, 22].
Conclusion
Cutaneous manifestations were found in all patients on dialysis. Most
common manifestation was xerosis. Other common problems were pruritus,
pigmentary changes. Most common nail change was half and half nail.
Hair changes were also common. Cutaneous infections were also common
problem. Timely recognition and management of these problems may
improve quality of life in dialysis patients.
Funding:
Nil
Conflict of interest:
Nil
Permission from IRB:
Yes
References
1. Pico MR, Lugo-Somolinos A, Sánchez JL,
Burgos-Calderón R. Cutaneous alterations in patients with
chronic renal failure. Int J Dermatol. 1992;31:860–3. [PubMed]
2. Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas
CR, Mathew AC. Cutaneous manifestations in patients with chronic renal
failure on hemodialysis.Indian J Dermatol Venerol Leprol .
2006;72(2):119-25. [PubMed]
3. Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG.
Pruritus and skin hydration during dialysis. Nephron Dial Transplant
1996 Oct;11(10):2031-6. [PubMed]
4. Z. Hajheydari and A. Makhlough..Cutaneous and mucosal manifestations
in patients on maintenance hemodialysis: a study of 101 patients in
Sari, Iran. Iranian Journal of Kidney Diseases
2002:2(2):86–90. [PubMed]
5. Tawade N, Gokhale BB. Dermatologic manifestation of chronic renal
failure. Indian J Dermatol Venereol Leprol 1996;62:155-6. [PubMed]
6. Siddappa K, Nair BK, Ravindra K, Siddesh ER. Skin in systemic
disease. In: Valia RG, Valia AR, editors. IADVL Textbook and atlas of
dermatology. 2nd ed. Bhalani Publishing House: Mumbai; 2000. pp. 938-84.
7. Weisman K. Graham RM. Systemic disease and the skin. In: Champion
RH, Burton JL, Burns DA. Breathnach SM, editors. Rook/ Wilkinson/
Ebling Textbook of dermatology. 6th ed. Blackwell Science: Oxford;
1998. pp. 2703-58. [PubMed]
8. Graham RM, Cox NH. Systemic disease and the skin. In: Burns DA,
Breathnach SM, Cox N, Griffiths CE, editors. Rook's textbook of
dermatology. 7 th ed. Oxford: Wiley-Blackwell; 2004: pp.59-75.
9. Gupta AK, Gupta MA, Cardella CJ, Haberman HF. Cutaneous associations
of chronic renal failure and dialysis.Int J Dermatol.
1986;25(8):498-504. [PubMed]
10. Deshmukh SP, Sharma YK, Dash K, Chaudhari NC, Deo KS.
Clinicoepidemiological study of skin manifestations in patients of
chronic renal failure on hemodialysis. Indian Dermatol Online J
2013;4:18-21. [PubMed]
11. Kato A, Hamada M, Maruyama T, Maruyama Y, Hishida A.
Pruritus and hydration state of stratum corneum in hemodialysis
patients.Am J Nephrl.2000:20(6):437-42. [PubMed]
12. Etter L, Myers SA. Pruritus in systemic disease: Mechanisms and
management. Dermatol Clin. 2002;20(3):459-472. [PubMed]
13. Smith AG, Shuster S, Comaish JS, Plummer NA, Thody AJ, Alvarez-Ude
F. Plasma immunoreactive β-Melanocyte stimulating hormone and
skin pigmentation in chronic renal failure. Br Med J 1975;1:658-9.
14. Tsaltas TT. Studies of lipochromes in uremic patients and normal
controls. II. Isolation and identification of carotenoids and
lipochromes and their oxidation products in plasma. Trans Am Soc Artif
Intern Organs 1970;16:272-8.
15. Beheshti A, Charkhchian M, Zangivand AA, Sedighi A, Amri G.
Dermatological Manifestations Among Patients on Maintenance
Hemodialysis. WOUNDS. 2013;25(3):61–67.
16. Sultan MM, Mansour HH, Wahby IM, Houdery AS. Cutaneous
manifestations in egyptians patients with chronic renal failure on
regular hemodialysis. J Egypt Women Dermatol Soc 2010;7:49-55.
17. Dyachenko P, Monselise A, Shustak A, Ziv M, Rozenman D. Nail
disorders in patients with chronic renal failure and undergoing
haemodialysis treatment: A case control study. J Eur Acad Dermatol
Venereol 2007;21:340-4.
18. Singh G, Singh SJ, Chakrabarthy N, Siddharaju KS, Prakash JC.
Cutaneous manifestations of chronic renal failure. Indian J Dermatol
Venereol Leprol 1989;55:167-9.
19. Gupta AK, Gupta MA, Cardella CJ, Haberman HF. Cutaneous
associations of chronic renal failure and dialysis. Int J Dermatol
1986;25:498-504. [PubMed]
20. Cohen GS. Renal disease. In: Lynch MA, editor. Burket's Oral
medicine: Diagnosis and treatment. 9th ed. Philadelphia:
Lippincott-Raven; 1997: pp487-509.
21. Remuzzi G. Bleeding in renal failure. Lancet 1988;28:1205-8. [PubMed]
22. Khanna D, Singhal A, Kalra OP. Comparison of cutaneous
manifestations in chronic kidney disease with or without dialysis.
Postgrad Med J 2010:86:641-47. [PubMed]
23. Lindsay RM, Briggs JD, Luke RG, Boyle IT, Kennedy AC. Gynecomastia
in chronic renal failure. Br Med J 1967;4:779-80. [PubMed]
How to cite this article?
Dorchhom K, Kumar A, Bansal N, Pandey AN, Mehta A, Bisth JS, Varma A.
Dermatological Manifestations of Patients with Chronic Kidney Disease
on Hemodialysis. Int J Med Res Rev 2014;2(6):529- 533.doi:10.17511/ijmrr.2014.i06.04